BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26985794)

  • 1. Hydroxychloroquine: A Brief Review on Screening, Toxicity, and Progression.
    Modi YS; Singh RP; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):207-17. PubMed ID: 26985794
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine Retinopathy in the Era of Advanced Imaging Modalities.
    Dahrouj M; Young L
    Int Ophthalmol Clin; 2020; 60(1):73-83. PubMed ID: 31855897
    [No Abstract]   [Full Text] [Related]  

  • 6. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
    Bhavsar KV; Mukkamala LK; Freund KB
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):377-9. PubMed ID: 25856825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
    Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
    Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus.
    Piggott KD; Apte R
    Indian J Ophthalmol; 2018 Dec; 66(12):1861-1862. PubMed ID: 30451203
    [No Abstract]   [Full Text] [Related]  

  • 12. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
    Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
    Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine-Induced Retinal Toxicity.
    Iselin KC; Marti P; Pless M
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):514-6. PubMed ID: 27116524
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine screening practice patterns within a large multispecialty ophthalmic practice.
    Au A; Parikh V; Modi YS; Ehlers JP; Schachat AP; Singh RP
    Am J Ophthalmol; 2015 Sep; 160(3):561-568.e2. PubMed ID: 26116260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASYMMETRIC HYDROXYCHLOROQUINE MACULAR TOXICITY WITH APHAKIC FELLOW EYE.
    Mack HG; Fuzzard DRW; Symons RCA; Heriot WJ
    Retin Cases Brief Rep; 2021 Mar; 15(2):176-178. PubMed ID: 29975258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract]   [Full Text] [Related]  

  • 19. Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.
    Allahdina AM; Stetson PF; Vitale S; Wong WT; Chew EY; Ferris FL; Sieving PA; Cukras C
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1953-1963. PubMed ID: 29677357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
    Melles RB; Marmor MF
    Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.